A prospective, randomized, multicenter, double-blind, phase IIIb study of Aripiprazole-lauroxil and Paliperidone palmitate in subjects experiencing an acute exacerbation of schizophrenia.
Phase of Trial: Phase III
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Aripiprazole lauroxil (Primary) ; Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Alkermes plc
- 27 Oct 2017 New trial record
- 26 Oct 2017 According to an Alkermes plc media release, company expects to initiate this study in November 2017.